December 22, 2000
THRESHOLDS DISCUSSION DOCUMENT AVAILABLE
The discussion document entitled; "An Approach for Establishing Thresholds in Association with the Use of Antimicrobial Drugs in Food-Producing Animals" is now available for review and comment. This document reflects the Center for Veterinary Medicine’s (CVM’s) current thinking on one concept for establishing resistance thresholds for antimicrobial drugs used in food-producing animals. The concept will be presented for discussion at a public meeting on January 22-24, 2001. CVM wants to receive comment on scientific and policy issues regarding this concept, as well as suggestions for alternative approaches.
The document may be found on FDA/Center for Veterinary Medicine (CVM) Home Page on the Internet at: threshold21.doc and threshold21.pdf. Individuals interested in this discussion document who do not have access to the Internet may obtain a copy by calling or writing CVM's Communications Staff at: FDA/Center for Veterinary Medicine, HFV-12, 7500 Standish Place, Rockville, MD 20855, 301-594-1755.
Written comments on the document may be submitted to Dockets Management Branch, (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Room 1061, Rockville, MD, 20852; or faxed to (301) 827-6870. Comments should be identified with the full title of the document and with Docket number 00D-1677. Comments should be submitted no later than 75 days after the January meeting.
Additional information may be obtained from Dr. Sharon R. Thompson, Center for Veterinary Medicine (HFV-3), Food and Drug Administration, 7519 Standish Place, Rockville, MD 20855, 301-827-4514, e-mail at sthompso@cvm.fda.gov or Dr. William T. Flynn, Center for Veterinary Medicine (HFV-100), Food and Drug Administration, 7500 Standish Place, Rockville, MD 20855, 301-827-7570, e-mail at wflynn@cvm.fda.gov.
Issued by:
FDA, Center for Veterinary Medicine,
Communications Staff, HFV-12
7519 Standish Place, Rockville, MD 20855
Telephone: (240) 276-9300 FAX: (240) 276-9115
Internet Web Site: http://www.fda.gov/cvm